Goldman Sachs Group Inc. Sells 40,931 Shares of HCA Healthcare, Inc. $HCA

Goldman Sachs Group Inc. cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 2.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,771,281 shares of the company’s stock after selling 40,931 shares during the quarter. Goldman Sachs Group Inc. owned about 0.78% of HCA Healthcare worth $826,941,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Capital World Investors lifted its position in shares of HCA Healthcare by 3.8% during the third quarter. Capital World Investors now owns 4,959,336 shares of the company’s stock worth $2,113,662,000 after purchasing an additional 179,443 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of HCA Healthcare by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock worth $1,702,738,000 after purchasing an additional 13,565 shares during the last quarter. Norges Bank bought a new stake in shares of HCA Healthcare during the fourth quarter worth $1,262,513,000. Arrowstreet Capital Limited Partnership lifted its position in shares of HCA Healthcare by 1.8% during the third quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company’s stock worth $880,199,000 after purchasing an additional 36,414 shares during the last quarter. Finally, Viking Global Investors LP raised its holdings in shares of HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after acquiring an additional 690,773 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. Royal Bank Of Canada decreased their price objective on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Wells Fargo & Company decreased their price objective on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a report on Monday, April 27th. Jefferies Financial Group restated a “buy” rating and issued a $525.00 price objective on shares of HCA Healthcare in a report on Friday, April 24th. TD Cowen cut their target price on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating on the stock in a research note on Monday, April 27th. Finally, Stephens cut their target price on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $515.77.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $364.00 on Thursday. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The firm has a market capitalization of $80.75 billion, a price-to-earnings ratio of 12.52, a PEG ratio of 1.16 and a beta of 1.12. The stock’s 50-day simple moving average is $444.21 and its 200-day simple moving average is $478.72.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter in the previous year, the firm posted $6.45 EPS. HCA Healthcare’s revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.9%. HCA Healthcare’s payout ratio is presently 10.73%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.